Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07604974
PHASE2

A Study to Assess the Safety, Tolerability and Efficacy of ION775

Sponsor: Ionis Pharmaceuticals, Inc.

View on ClinicalTrials.gov

Summary

The main objective of this study is to evaluate the effect of ION775 on fasting triglyceride (TG) levels in participants with hypertriglyceridemia (HTG) and severe hypertriglyceridemia (sHTG).

Official title: A Phase 2, Open-label Trial Evaluating the Safety, Tolerability and Efficacy of ION775 in Adults With Hypertriglyceridemia

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

72

Start Date

2026-05-12

Completion Date

2028-03

Last Updated

2026-06-15

Healthy Volunteers

No

Interventions

DRUG

ION775

ION775 will be administered by SC injection.

Locations (8)

Ionis Investigative Site

Lincoln, California, United States

Ionis Investigative Site

Miami, Florida, United States

Ionis Investigative Site

Miramar, Florida, United States

Ionis Investigative Site

Flint, Michigan, United States

Ionis Investigative Site

Munroe Falls, Ohio, United States

Ionis Investigative Site

Little River, South Carolina, United States

Ionis Investigative Site

Lampasas, Texas, United States

Ionis Investigative Site

San Antonio, Texas, United States